EP0680517B2
(de)
*
|
1993-01-21 |
2005-01-19 |
President And Fellows Of Harvard College |
Verfahren und diagnostische kits unter verwendung von säuger-stresspromotoren zur bestimmung der toxizität einer verbindung
|
WO1995007463A1
(en)
*
|
1993-09-10 |
1995-03-16 |
The Trustees Of Columbia University In The City Of New York |
Uses of green fluorescent protein
|
GB9420735D0
(en)
*
|
1994-10-14 |
1994-11-30 |
Karobio Ab |
Reporter cell line
|
GB9424497D0
(en)
*
|
1994-12-05 |
1995-01-25 |
Karobio Ab |
Reporter cell line
|
US6387651B1
(en)
|
1995-04-12 |
2002-05-14 |
Biolog, Inc. |
Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a microwell device
|
US5777888A
(en)
*
|
1995-08-09 |
1998-07-07 |
Regents Of The University Of California |
Systems for generating and analyzing stimulus-response output signal matrices
|
US6326140B1
(en)
|
1995-08-09 |
2001-12-04 |
Regents Of The University Of California |
Systems for generating and analyzing stimulus-response output signal matrices
|
US5569588A
(en)
*
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
GB9526509D0
(en)
*
|
1995-12-23 |
1996-02-28 |
Univ Dundee |
Gene control
|
US6110671A
(en)
*
|
1996-04-04 |
2000-08-29 |
The United States Of America As Represented By The Secretary Of The Army |
Method of measuring tumor suppressor gene p53
|
US5928888A
(en)
*
|
1996-09-26 |
1999-07-27 |
Aurora Biosciences Corporation |
Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
|
US6165709A
(en)
|
1997-02-28 |
2000-12-26 |
Fred Hutchinson Cancer Research Center |
Methods for drug target screening
|
IL131336A0
(en)
*
|
1997-02-28 |
2001-01-28 |
Du Pont |
A method for identifying the site of action of xenobiotic chemicals
|
GB9706414D0
(en)
|
1997-03-27 |
1997-05-14 |
Univ Manchester |
Detection of DNA damage
|
US7031843B1
(en)
*
|
1997-09-23 |
2006-04-18 |
Gene Logic Inc. |
Computer methods and systems for displaying information relating to gene expression data
|
WO1999016903A1
(fr)
*
|
1997-09-29 |
1999-04-08 |
Hsp Research Institute, Inc. |
Procede de criblage des regulateurs de l'induction de l'expression de proteines de choc thermique
|
CA2310621A1
(en)
*
|
1997-11-20 |
1999-06-03 |
Smithkline Beecham Corporation |
Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
|
CA2321931A1
(en)
*
|
1998-03-06 |
1999-09-10 |
E.I. Du Pont De Nemours And Company |
Methods for identifying polycationic, peptide-like compounds with antibacterial activity
|
US5965352A
(en)
*
|
1998-05-08 |
1999-10-12 |
Rosetta Inpharmatics, Inc. |
Methods for identifying pathways of drug action
|
AU750975B2
(en)
*
|
1998-05-12 |
2002-08-01 |
Rosetta Inpharmatics, Inc. |
Quantitative methods, systems and apparatuses for gene expression analysis
|
US6132969A
(en)
*
|
1998-06-19 |
2000-10-17 |
Rosetta Inpharmatics, Inc. |
Methods for testing biological network models
|
US6501003B1
(en)
*
|
1998-07-08 |
2002-12-31 |
Wisconsin Alumni Research Foundation |
Transgentic mouse expressing green fluorescent protein in glial cells
|
US20030105044A1
(en)
*
|
2001-10-17 |
2003-06-05 |
Isis Pharmaceuticals Inc. |
Antisense modulation of matrix metalloproteinase 1 expression
|
US6593084B2
(en)
|
1998-10-13 |
2003-07-15 |
Robert E. Bird |
Carcinogen assay
|
US6468476B1
(en)
|
1998-10-27 |
2002-10-22 |
Rosetta Inpharmatics, Inc. |
Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns
|
US6950752B1
(en)
|
1998-10-27 |
2005-09-27 |
Rosetta Inpharmatics Llc |
Methods for removing artifact from biological profiles
|
US6203987B1
(en)
|
1998-10-27 |
2001-03-20 |
Rosetta Inpharmatics, Inc. |
Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
|
US6453241B1
(en)
*
|
1998-12-23 |
2002-09-17 |
Rosetta Inpharmatics, Inc. |
Method and system for analyzing biological response signal data
|
US6801859B1
(en)
|
1998-12-23 |
2004-10-05 |
Rosetta Inpharmatics Llc |
Methods of characterizing drug activities using consensus profiles
|
US6370478B1
(en)
|
1998-12-28 |
2002-04-09 |
Rosetta Inpharmatics, Inc. |
Methods for drug interaction prediction using biological response profiles
|
US6222093B1
(en)
|
1998-12-28 |
2001-04-24 |
Rosetta Inpharmatics, Inc. |
Methods for determining therapeutic index from gene expression profiles
|
WO2000058457A2
(en)
*
|
1999-03-31 |
2000-10-05 |
Rosetta Inpharmatics, Inc. |
Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs
|
DE60030796T2
(de)
|
1999-04-14 |
2007-09-13 |
Sumitomo Chemical Co., Ltd. |
Zelle zur Bestimmung der Fähigkeit die Aktivität eines Liganden-abhängigen Transkriptionskontrollfaktors zu kontrollieren
|
EP2293056A3
(de)
|
1999-04-20 |
2011-06-29 |
Target Discovery, Inc. |
Verfahren zur Analyse eines Stoffwechselweges
|
US6673554B1
(en)
|
1999-06-14 |
2004-01-06 |
Trellie Bioinformatics, Inc. |
Protein localization assays for toxicity and antidotes thereto
|
US7049132B1
(en)
|
1999-06-28 |
2006-05-23 |
University Of Southern California |
Stress-responsive induction of a therapeutic agent and methods of use
|
US20050060101A1
(en)
*
|
1999-06-28 |
2005-03-17 |
Bevilacqua Michael P. |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
|
US20060115826A1
(en)
*
|
1999-06-28 |
2006-06-01 |
Michael Bevilacqua |
Gene expression profiling for identification monitoring and treatment of multiple sclerosis
|
WO2001000791A1
(en)
*
|
1999-06-28 |
2001-01-04 |
University Of Southern California |
Stress-responsive induction of a therapeutic agent and methods of use
|
US20080183395A1
(en)
*
|
1999-06-28 |
2008-07-31 |
Michael Bevilacqua |
Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
|
US6692916B2
(en)
*
|
1999-06-28 |
2004-02-17 |
Source Precision Medicine, Inc. |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
|
US6960439B2
(en)
|
1999-06-28 |
2005-11-01 |
Source Precision Medicine, Inc. |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
|
US20040225449A1
(en)
*
|
1999-06-28 |
2004-11-11 |
Bevilacqua Michael P. |
Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
|
US6931396B1
(en)
|
1999-06-29 |
2005-08-16 |
Gene Logic Inc. |
Biological data processing
|
US20020087511A1
(en)
*
|
1999-09-02 |
2002-07-04 |
Johnson Peter C. |
Methods for profiling and manufacturing tissue using a database that includes indices representative of a tissue population
|
US6727100B1
(en)
*
|
1999-10-21 |
2004-04-27 |
4Sc Ag |
Method of identifying candidate molecules
|
GB2355791B
(en)
*
|
1999-10-28 |
2004-10-20 |
Molecular Light Tech Res Ltd |
Detection of mRNA expression using chemiluminescent labelled probes
|
EP1130086A1
(de)
*
|
2000-02-18 |
2001-09-05 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Genetische manipulierte Keratinozyten und deren Verwendung zur Prüfung der Toxizität
|
US20040115627A1
(en)
*
|
2000-04-12 |
2004-06-17 |
Judy Raucy |
Compositions and methods for induction of proteins involved in xenobiotic metabolism
|
US6696239B1
(en)
|
2000-04-20 |
2004-02-24 |
Biolog, Inc. |
Comparative phenotype analysis for assessment of biological active compounds such as antimicrobials
|
NZ539223A
(en)
*
|
2000-05-16 |
2006-10-27 |
Childrens Mercy Hospital |
Single copy genomic hybridization probes and method of generating same
|
US6828097B1
(en)
*
|
2000-05-16 |
2004-12-07 |
The Childrens Mercy Hospital |
Single copy genomic hybridization probes and method of generating same
|
US20030171876A1
(en)
*
|
2002-03-05 |
2003-09-11 |
Victor Markowitz |
System and method for managing gene expression data
|
US6902882B2
(en)
|
2000-05-23 |
2005-06-07 |
Kerong Gu |
Methods of monitoring production of gene products and uses thereof
|
US7020561B1
(en)
|
2000-05-23 |
2006-03-28 |
Gene Logic, Inc. |
Methods and systems for efficient comparison, identification, processing, and importing of gene expression data
|
AU2001268449A1
(en)
|
2000-06-14 |
2001-12-24 |
Vistagen, Inc. |
Toxicity typing using liver stem cells
|
EP1301632A2
(de)
*
|
2000-07-19 |
2003-04-16 |
Pointilliste, Inc. |
Eingebettetes sortieren und hochdurchsatzscreening
|
EP1409718A2
(de)
*
|
2000-07-21 |
2004-04-21 |
Phase-1 Molecular Toxicology |
Hundegene im zusammenhang mit toxizität
|
US7613571B2
(en)
*
|
2000-07-28 |
2009-11-03 |
Doyle Michael D |
Method and system for the multidimensional morphological reconstruction of genome expression activity
|
US7590493B2
(en)
*
|
2000-07-31 |
2009-09-15 |
Ocimum Biosolutions, Inc. |
Methods for determining hepatotoxins
|
AU2001280889A1
(en)
*
|
2000-07-31 |
2002-02-13 |
Gene Logic, Inc. |
Molecular toxicology modeling
|
CA2327581A1
(en)
*
|
2000-12-27 |
2002-06-27 |
Yves Blais |
Methods and compositions for the establishment of genetically altered cell-based library designed for monitoring transcriptional activity of compounds and molecules
|
WO2002059560A2
(en)
*
|
2001-01-23 |
2002-08-01 |
Gene Logic, Inc. |
A method and system for predicting the biological activity, including toxicology and toxicity, of substances
|
US7405081B2
(en)
*
|
2001-02-05 |
2008-07-29 |
Pan Shen Q |
Methods and kits for identifying scavengers of reactive oxygen species (ROS)
|
CA2438832A1
(en)
*
|
2001-02-23 |
2002-09-06 |
Elan Pharmaceuticals, Inc. |
Transgenic knockouts of bace-1
|
WO2002073504A1
(en)
*
|
2001-03-14 |
2002-09-19 |
Gene Logic, Inc. |
A system and method for retrieving and using gene expression data from multiple sources
|
AU2002303234A1
(en)
*
|
2001-04-02 |
2002-10-15 |
Cytoprint, Inc. |
Methods and apparatus for discovering, identifying and comparing biological activity mechanisms
|
US20070015146A1
(en)
*
|
2001-05-22 |
2007-01-18 |
Gene Logic, Inc. |
Molecular nephrotoxicology modeling
|
US7415358B2
(en)
*
|
2001-05-22 |
2008-08-19 |
Ocimum Biosolutions, Inc. |
Molecular toxicology modeling
|
WO2003068908A2
(en)
*
|
2001-07-10 |
2003-08-21 |
Gene Logic, Inc. |
Cardiotoxin molecular toxicology modeling
|
US7447594B2
(en)
*
|
2001-07-10 |
2008-11-04 |
Ocimum Biosolutions, Inc. |
Molecular cardiotoxicology modeling
|
US20070054269A1
(en)
*
|
2001-07-10 |
2007-03-08 |
Mendrick Donna L |
Molecular cardiotoxicology modeling
|
US20030143612A1
(en)
*
|
2001-07-18 |
2003-07-31 |
Pointilliste, Inc. |
Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
|
US7251642B1
(en)
|
2001-08-06 |
2007-07-31 |
Gene Logic Inc. |
Analysis engine and work space manager for use with gene expression data
|
WO2003016500A2
(en)
*
|
2001-08-16 |
2003-02-27 |
Phase-1 Molecular Toxicology, Inc. |
Human toxicologically relevant genes and arrays
|
WO2003018839A1
(en)
*
|
2001-08-23 |
2003-03-06 |
University College Dublin, National University Of Ireland, Dublin |
Identification of a common promoter module in disease associated genes
|
JP2003079365A
(ja)
|
2001-09-07 |
2003-03-18 |
Kanegafuchi Chem Ind Co Ltd |
環境有害化学物質の高感度検出法
|
US7842498B2
(en)
|
2001-11-08 |
2010-11-30 |
Bio-Rad Laboratories, Inc. |
Hydrophobic surface chip
|
KR20040064275A
(ko)
|
2001-11-09 |
2004-07-16 |
소스 프리시전 메디슨, 인코포레이티드 |
유전자 발현 프로파일을 이용한 질병의 동정, 모니터링,치료 및 생물학적 상태의 확인
|
CA2472030A1
(en)
*
|
2002-01-24 |
2003-07-31 |
Pointilliste, Inc. |
Use of collections of binding sites for sample profiling and other applications
|
US7704272B2
(en)
|
2002-01-31 |
2010-04-27 |
University Of Rochester |
Method for introducing an ultraviolet light activated viral vector into the spinal column
|
WO2003064624A2
(en)
*
|
2002-01-31 |
2003-08-07 |
Gene Logic, Inc. |
Molecular hepatotoxicology modeling
|
DE60310525T2
(de)
|
2002-01-31 |
2007-10-04 |
University Of Rochester Medical Center Office Of Technology Transfer |
Ultraviolette licht zur lichtaktivierten gentransduktion bei der genzuführung
|
US7469185B2
(en)
*
|
2002-02-04 |
2008-12-23 |
Ocimum Biosolutions, Inc. |
Primary rat hepatocyte toxicity modeling
|
RU2004136990A
(ru)
*
|
2002-05-17 |
2005-08-10 |
Байлор Колледж Оф Медсин (Us) |
Дифференциальные картины экспрессии генов, которые предсказывают хемочувствительность и хеморезистентность к доцетакселу
|
ITTO20020729A1
(it)
*
|
2002-08-14 |
2004-02-15 |
Consorzio Interuniversitario Per Le Biotecnologie |
Cellule di mammifero non umano geneticamente modificate, procedimento per la loro produzione e utilizzo in test di tossicita'.
|
AU2003291677A1
(en)
*
|
2002-10-30 |
2004-05-25 |
Pointilliste, Inc. |
Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
|
AU2003290561A1
(en)
*
|
2003-02-10 |
2004-09-06 |
Dana Ault-Riche |
Self-assembling arrays and uses thereof
|
US7853406B2
(en)
|
2003-06-13 |
2010-12-14 |
Entelos, Inc. |
Predictive toxicology for biological systems
|
US7727752B2
(en)
|
2003-07-29 |
2010-06-01 |
Life Technologies Corporation |
Kinase and phosphatase assays
|
US20070055448A1
(en)
*
|
2003-08-07 |
2007-03-08 |
Gene Logic Inc. |
Primary rat hepatocyte toxicity modeling
|
WO2005045426A2
(en)
*
|
2003-11-10 |
2005-05-19 |
Aic |
Gene expression profiling of hazardous compounds and corresponding database clustering algorithm
|
US20080281526A1
(en)
*
|
2004-03-22 |
2008-11-13 |
Diggans James C |
Methods For Molecular Toxicology Modeling
|
EP1751303A2
(de)
*
|
2004-04-07 |
2007-02-14 |
Gene Logic, Inc. |
Molekulare hepatotoxizitätsmodelle
|
GB0410105D0
(en)
*
|
2004-05-06 |
2004-06-09 |
Amersham Biosciences Uk Ltd |
Method for characterising compounds
|
WO2006017559A1
(en)
*
|
2004-08-02 |
2006-02-16 |
University Of Iowa Research Foundation |
Methods of inhibiting manganese-containing superoxide dismutase 2 (mnsod)
|
US7646450B2
(en)
*
|
2005-12-29 |
2010-01-12 |
Lg Display Co., Ltd. |
Light emitting diode array, method of manufacturing the same, backlight assembly having the same, and LCD having the same
|
WO2007092938A2
(en)
*
|
2006-02-08 |
2007-08-16 |
Invitrogen Corporation |
Cellular assays for signaling receptors
|
EP2069794A1
(de)
*
|
2006-10-03 |
2009-06-17 |
University of Southern California |
Grp78 als mittel zur vorhersage der ansprechbarkeit auf therapeutika
|
JP2010540534A
(ja)
*
|
2007-09-28 |
2010-12-24 |
イントレキソン コーポレーション |
生体治療分子の発現のための治療遺伝子スイッチ構築物およびバイオリアクター、ならびにその使用
|
AU2009302804B2
(en)
|
2008-10-08 |
2015-07-02 |
Intrexon Corporation |
Engineered cells expressing multiple immunomodulators and uses thereof
|
EP2199794A1
(de)
|
2008-12-17 |
2010-06-23 |
Universiteit Maastricht |
Verfahren zur Identifizierung von krebserregenden Verbindungen
|
CN103582704A
(zh)
*
|
2011-04-08 |
2014-02-12 |
安瑟生物科技私人有限公司 |
用于高通量筛选真核细胞中基因毒性剂的体外方法
|
EP2748338B1
(de)
*
|
2011-09-08 |
2017-04-26 |
Attagene, Inc. |
Systeme und verfahren für ein assay aus biokontaminantien in wasser
|
WO2019070704A1
(en)
*
|
2017-10-02 |
2019-04-11 |
Georgia Tech Research Corporation |
METHODS AND COMPOSITIONS FOR ENGINEERING SYNTHESIS BIOLOGICAL SWITCHES FOR REMOTE CONTROL OF BIOLOGICAL ACTIVITY
|
US20200367792A1
(en)
|
2018-02-09 |
2020-11-26 |
W.L. Gore & Associates, Inc. |
Implantable access chamber and associated methods of use
|
KR102382748B1
(ko)
*
|
2020-07-28 |
2022-04-05 |
가톨릭대학교 산학협력단 |
Egr1 프로모터 영역을 포함하는 재조합 벡터 및 이의 용도
|